familial hypercholesterolemia in iran: a novel frameshift mutation in low density lipoprotein receptor (ldlr) gene

Authors

pezhman fard-esfahani

shohreh khatami

abstract

background and objective: familial hypercholesterolemia (fh) is an autosomal trait, which is caused by mutations in low density lipoprotein receptor (ldlr) gene. fh penetrance is about 100% and worldwide prevalence for heterozygous subjects is almost 1 in 500 and for homozygous 1 in 1,000,000. the patients are at risk of premature coronary heart disease (chd) due to defective ldlr and hence cholesterol metabolism disorder. the aim of this study was identifying genotype of possible mutation in an iranian fh patient. materials and methods: promoter and all 18 exons including exon-intron boundaries of ldlr gene were scanned. polymerase chain reaction - single strand conformation polymorphism (pcr-sscp) was used as mutation scanning method. dna sequencing was used to identify any nucleotide change(s).  results: a new frameshift mutation (660-661inscc) was found in proband. conclusion: this mutation causes a truncated, non-functional protein, which results in hypercholesterolemia. the mutation can be screened in proband's relatives to find other fh patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Familial Hypercholesterolemia in Iran: A Novel Frameshift Mutation in Low Density Lipoprotein Receptor (LDLR) Gene

  Background and Objective: Familial hypercholesterolemia (FH) is an autosomal trait, which is caused by mutations in Low Density Lipoprotein Receptor (LDLR) gene. FH penetrance is about 100% and worldwide prevalence for heterozygous subjects is almost 1 in 500 and for homozygous 1 in 1,000,000. The patients are at risk of premature coronary heart disease (CHD) due to defective LDLR a...

full text

Familial Hypercholesterolemia in Iran: A Novel Frameshift Mutation in Low Density Lipoprotein Receptor (LDLR) Gene

Background and Objective: Familial hypercholesterolemia (FH) is an autosomal trait, which is caused by mutations in Low Density Lipoprotein Receptor (LDLR) gene. FH penetrance is about 100% and worldwide prevalence for heterozygous subjects is almost 1 in 500 and for homozygous 1 in 1,000,000. The patients are at risk of premature coronary heart disease (CHD) due to defective LDLR and hence cho...

full text

A Novel Mutation in Exon 4 of the Low Density Lipoprotein (LDL) Receptor Gene in an Iranian Familial Hypercholesterolemia Patient

Familial hypercholesterolemia (FH) is an autosomal co-dominant disorder of lipid metabolism, caused by mutations in LDL receptor gene. The penetrance of FH is almost 100%, meaning that half of the offspring of affected parents born with disease. The patients are at risk of premature coronary heart disease (CHD). There is no report about the molecular basis of FH in Iran. Identification of mutat...

full text

a novel mutation in exon 4 of the low density lipoprotein (ldl) receptor gene in an iranian familial hypercholesterolemia patient

familial hypercholesterolemia (fh) is an autosomal co-dominant disorder of lipid metabolism, caused by mutations in ldl receptor gene. the penetrance of fh is almost 100%, meaning that half of the offspring of affected parents born with disease. the patients are at risk of premature coronary heart disease (chd). there is no report about the molecular basis of fh in iran. identification of mutat...

full text

A Novel Mutation in Exon 4 of the Low Density Lipoprotein (LDL) Receptor Gene in an Iranian Familial Hypercholesterolemia Patient

Familial hypercholesterolemia (FH) is an autosomal co-dominant disorder of lipid metabolism, caused by mutations in LDL receptor gene. The penetrance of FH is almost 100%, meaning that half of the offspring of affected parents born with disease. The patients are at risk of premature coronary heart disease (CHD). There is no report about the molecular basis of FH in Iran. Identification of mutat...

full text

Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients.

It has been reported that in China, patients with heterozygous familial hypercholesterolemia (FH) may go unrecognized because they do not have xanthomata or premature coronary heart disease and their LDL cholesterol levels are lower than those in their Western counterparts. However, in the Chinese patients in Hong Kong, heterozygous FH appears to manifest in a way similar to that seen in Wester...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pathology

Publisher: iranian society of pathology

ISSN 1735-5303

volume 5

issue 1 2010

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023